rs886061943

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_000245.4(MET):​c.1174C>A​(p.Pro392Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000207 in 1,451,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P392H) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

MET
NM_000245.4 missense

Scores

5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 4.92

Publications

0 publications found
Variant links:
Genes affected
MET (HGNC:7029): (MET proto-oncogene, receptor tyrosine kinase) This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers. [provided by RefSeq, May 2016]
COMETT (HGNC:51196): (cytosolic oncogenic antisense to MET transcript) This gene encodes a natural antisense transcript highly expressed in papillary thyroid carcinomas harboring BRAF V600E mutation or RET gene rearrangements. This lncRNA induces the downstream MAPK pathway and is part of a co-expression network including different oncogenes belonging to the MAPK and PI3H/AKT pathways. In thyroid carcinomas, this gene has oncogenic properties associated with increased proliferation and drug resistance. [provided by RefSeq, Jan 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22628394).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000245.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MET
NM_000245.4
MANE Select
c.1174C>Ap.Pro392Thr
missense
Exon 2 of 21NP_000236.2
MET
NM_001127500.3
c.1174C>Ap.Pro392Thr
missense
Exon 2 of 21NP_001120972.1P08581-2
MET
NM_001324401.3
c.1174C>Ap.Pro392Thr
missense
Exon 2 of 12NP_001311330.1E6Y365

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MET
ENST00000397752.8
TSL:1 MANE Select
c.1174C>Ap.Pro392Thr
missense
Exon 2 of 21ENSP00000380860.3P08581-1
MET
ENST00000318493.11
TSL:1
c.1174C>Ap.Pro392Thr
missense
Exon 2 of 21ENSP00000317272.6P08581-2
MET
ENST00000436117.3
TSL:1
n.1174C>A
non_coding_transcript_exon
Exon 2 of 20ENSP00000410980.2P08581-3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
237730
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000207
AC:
3
AN:
1451150
Hom.:
0
Cov.:
32
AF XY:
0.00000277
AC XY:
2
AN XY:
721574
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32914
American (AMR)
AF:
0.00
AC:
0
AN:
42526
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25738
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39664
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50688
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5726
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1110028
Other (OTH)
AF:
0.0000167
AC:
1
AN:
60056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Autosomal recessive nonsyndromic hearing loss 97 (1)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
1
-
not specified (1)
-
1
-
Papillary renal cell carcinoma type 1 (1)
-
1
-
Papillary renal cell carcinoma type 1;C2239176:Hepatocellular carcinoma;C4084709:Autosomal recessive nonsyndromic hearing loss 97;C4085248:Osteofibrous dysplasia (1)
-
1
-
Renal cell carcinoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.28
T
Eigen
Uncertain
0.30
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Benign
0.75
D
LIST_S2
Uncertain
0.90
D
M_CAP
Benign
0.0046
T
MetaRNN
Benign
0.23
T
MetaSVM
Benign
-1.2
T
MutationAssessor
Benign
1.5
L
PhyloP100
4.9
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-2.1
N
REVEL
Benign
0.10
Sift
Uncertain
0.027
D
Sift4G
Benign
0.29
T
Polyphen
0.77
P
Vest4
0.34
MutPred
0.56
Gain of catalytic residue at P392 (P = 0.0222)
MVP
0.27
MPC
0.49
ClinPred
0.58
D
GERP RS
5.1
Varity_R
0.24
gMVP
0.67
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs886061943; hg19: chr7-116340312; API